Possible Correlations between the COVID-19 mRNA Vaccine and Contracting Myocarditis/Pericarditis in Young Adults

Abstract

mRNA vaccines have been pivotal in the management of global health in regulating the spread and severity of COVID-19 across the world. Approximately six months post vaccine, there was concerns raised by the Food and Drug Administration (FDA) over the adverse events of inflammatory heart conditions in the younger adult demographic aged between 18-24 years old following vaccination in particular mRNA. This article will look at possible correlations between the delivery of the mRNA vaccine and the effect it has had on the younger adult population.